Daratumumab proves safe and highly effective in AL amyloidosis

Abstract

dlof, M. & Ranki, A. (1999) Notable losses at specific regions of chromosomes 10q and 13q in the Sezary syndrome detected by comparative genomic hybridization. The Journal of Investigative Dermatology, 112, 392–395. Li, Z., Cai, X., Cai, C.-L., Wang, J., Zhang, W., Petersen, B.E., Yang, F.-C. & Xu, M. (2011) Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies. Blood, 118, 4509–4518. Lossos, C., Ferrell, A., Duncan, R. & Lossos, I.S. (2011) Association between non-Hodgkin lymphoma and renal cell carcinoma. Leukaemia & Lymphoma, 52, 2254–2261. Olsen, E.A., Delzell, E. & Jegasothy, B.V. (1984) Second malignancies in cutaneous T-cell lymphoma. Journal of the American Academy of Dermatology, 10, 197–204. Petersen, I., Langreck, H., Wolf, G., Schwendel, A., Psille, R., Vogt, P., Reichel, M.B., Ried, T. & Dietel, M. (1997) Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q and 17p. British Journal of Cancer, 75, 79–86. Tadmor, T., Barbara, S., Liphshiz, I. & Polliack, A. (2014) Risk of second malignancies after non Hodgkin lymphoma: a cohort study of 22,466 survivors in Israel. Blood, 124, 5375–5375.